APIs and Excipients

Drug Solutions Podcast: Innovations and Advances in Drug Dosage Forms

August 01, 2023

In this episode, David Tisi and Reenal Gandhi provide expert insights into advances and innovations changing the drug dosage form landscape.

Teva Pharmaceuticals and Alvotech Expand Existing Biosimilars Partnership

July 27, 2023

Teva Pharmaceuticals and Alvotech will expand their partnership for the development and commercialization of biosimilar candidates.

EMA Gives Positive Opinion on Two of Janssen’s Bispecific Antibodies

July 27, 2023

Janssen has received a positive opinion from the EMA for two novel bispecific antibodies, TALVEY (talquetamab) and TECVAYLI (teclistamab), which the company is developing to treat blood cancer.

Crossbow Therapeutics Debuts with $80 Million in Series A Financing to Advance Antibody Therapeutics

July 24, 2023

Newly launched Crossbow Therapeutics will work to advance a novel class of antibody therapies for treating cancers.

Chime Biologics Forms mAb Development and Manufacturing Deal with Leads Biolabs and BeiGene

July 06, 2023

Chime Biologics, Leads Biolabs, and BeiGene have formed a three-way collaboration to advance the development and global manufacturing of Leads Biolabs’ lead mAb candidate, LBL-007.

Overcoming Analytical Challenges in High Potency Formulation

July 03, 2023

Sample dilution, sensitivity, excipient interference, and containment are key issues that must be addressed.

Aenova Opens New Building for Highly Potent Drugs

June 23, 2023

Aenova has opened a new building for the production of highly potent APIs in Germany.

Croda Pharma Breaks Ground on Excipients Manufacturing Facility

June 14, 2023

The new excipients manufacturing facility is expected to be completed in 2025.

invoX Pharma Invests in pHion Therapeutics to Develop Next-Generation mRNA Vaccines

June 06, 2023

invoX Pharma has made a second tranche of investment in pHion Therapeutics to support further development of next-generation mRNA vaccines.

Overcoming the Poor Solubility of Cannabinoids

June 02, 2023

Nanotech-based delivery technologies are receiving significant attention.